Search

Search Results

• 

  Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study

  Carlos A. Jiménez-Ruiz, Marcos Garcia Rueda, Manuel A. Martinez Muñiz, Jacobo Sellarés, Maria A. Jiménez-Fuentes, Lourdes Lázaro Asegurado, Esther Rodríguez Gonzalez, Concepción Rodriguez Garcia, Oriol Armengol, Emilia Abad, Teresa Peña, Adolfo Domenech del Rio, Juan A. Riesco Miranda

  2017-12-19

  https://doi.org/10.4081/monaldi.2017.874

  1735

  PDF: 948

  Supplementary: 254

• Varenicline and evaluated outcomes in smoking cessation programmes

  P. Santus, L. Bassi, A. Airoldi, F. Giovannelli, D. Radovanovic

  2015-11-26

  https://doi.org/10.4081/monaldi.2013.105

  1178

  PDF: 654

• Smoking cessation treatment for COPD smokers: the role of pharmacological interventions

  C.A. Jiménez-Ruiz, K.O. Fagerström

  2015-11-26

  https://doi.org/10.4081/monaldi.2013.106

  2731

  PDF: 1559

• Smoking cessation interventions after Acute Coronary Syndromes. Results of a cross-sectional survey in the Lazio Region of Italy

  Furio Colivicchi, David Mocini, Massimo Uguccioni, Stefano Strano, Giuseppe Imperoli, Massimo Santini

  2015-12-01

  https://doi.org/10.4081/monaldi.2012.128

  974

  PDF: 663

• Smoking cessation and its significant role in the Indian scenario

  Raj Kumar, Manoj Kumar, Sukriti Raj, Dileep Kumar Arisham, Anil Kumar Mavi, Kamal Singh

  2023-12-04

  https://doi.org/10.4081/monaldi.2023.2814

  1438

  PDF: 265